New tripeptide-based macrocyclic calpain inhibitors formed by N-alkylation of histidine

Chem Biodivers. 2012 Nov;9(11):2473-84. doi: 10.1002/cbdv.201200320.

Abstract

Two new series of 15-membered macrocyclic peptidomimetics, in which the P1 and P3 residues of the peptide backbone are linked by a bridge containing a 1,4-disubstituted 1H-imidazole, are reported. The structure with an aldehyde at the C-terminus and the imidazole at P3, i.e., 4c, shows significant inhibitory activity against calpain 2, with an IC(50) value of 238 nM. The macrocyclic aldehyde with the imidazole at the alternative P1 position, i.e., 5c, is significantly less active. The relative activities are linked to the ability of the component macrocycles to mimic a β-strand geometry that is known to favor active-site binding. This ability is defined by conformational searches and docking studies with calpain.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkylation
  • Animals
  • Calpain / antagonists & inhibitors*
  • Calpain / metabolism
  • Cysteine Proteinase Inhibitors / chemistry*
  • Cysteine Proteinase Inhibitors / pharmacology*
  • Glycoproteins / chemistry*
  • Glycoproteins / pharmacology*
  • Histidine / chemistry
  • Histidine / pharmacology
  • Humans
  • Macrocyclic Compounds / chemical synthesis
  • Macrocyclic Compounds / chemistry
  • Macrocyclic Compounds / pharmacology
  • Molecular Docking Simulation
  • Peptidomimetics / chemistry*
  • Peptidomimetics / pharmacology*
  • Protein Structure, Secondary

Substances

  • Cysteine Proteinase Inhibitors
  • Glycoproteins
  • Macrocyclic Compounds
  • Peptidomimetics
  • calpain inhibitors
  • Histidine
  • Calpain